AU2020901810A0 - Methods for treating major depressive disorder and treatment-resistant depression - Google Patents

Methods for treating major depressive disorder and treatment-resistant depression

Info

Publication number
AU2020901810A0
AU2020901810A0 AU2020901810A AU2020901810A AU2020901810A0 AU 2020901810 A0 AU2020901810 A0 AU 2020901810A0 AU 2020901810 A AU2020901810 A AU 2020901810A AU 2020901810 A AU2020901810 A AU 2020901810A AU 2020901810 A0 AU2020901810 A0 AU 2020901810A0
Authority
AU
Australia
Prior art keywords
treatment
methods
depressive disorder
major depressive
resistant depression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901810A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
iX Biopharma Pty Ltd
IX BIOPHARMA Ltd
Original Assignee
iX Biopharma Pty Ltd
IX BIOPHARMA Ltd
Filing date
Publication date
Application filed by iX Biopharma Pty Ltd, IX BIOPHARMA Ltd filed Critical iX Biopharma Pty Ltd
Publication of AU2020901810A0 publication Critical patent/AU2020901810A0/en
Priority to US18/000,497 priority Critical patent/US20230210789A1/en
Priority to EP21817463.9A priority patent/EP4157244A1/en
Priority to IL298732A priority patent/IL298732A/en
Priority to CA3180964A priority patent/CA3180964A1/en
Priority to PCT/AU2021/050519 priority patent/WO2021243399A1/en
Priority to AU2021285083A priority patent/AU2021285083A1/en
Priority to CN202180060013.6A priority patent/CN117561082A/en
Pending legal-status Critical Current

Links

AU2020901810A 2020-06-02 2020-06-02 Methods for treating major depressive disorder and treatment-resistant depression Pending AU2020901810A0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US18/000,497 US20230210789A1 (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
EP21817463.9A EP4157244A1 (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
IL298732A IL298732A (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
CA3180964A CA3180964A1 (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
PCT/AU2021/050519 WO2021243399A1 (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
AU2021285083A AU2021285083A1 (en) 2020-06-02 2021-05-28 Methods for treating major depressive disorder and treatment-resistant depression
CN202180060013.6A CN117561082A (en) 2020-06-02 2021-05-28 Method for treating major depressive disorder and refractory depression

Publications (1)

Publication Number Publication Date
AU2020901810A0 true AU2020901810A0 (en) 2020-06-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3999548A4 (en) Claudin18 antibodies and methods of treating cancer
EP3630054A4 (en) Kits and methods for treating hair
EP3814525A4 (en) Treatment methods and biomarkers for mdm2 inhibitors
IL288086A (en) Methods and materials for treating cancer
EP4136254A4 (en) Ace2-targeted compositions and methods for treating covid-19
EP4041225A4 (en) Methods and materials for treating neurotoxicity
GB202105597D0 (en) Software application and related methods
EP4041312A4 (en) Methods of treating an eye disorder
EP4048396A4 (en) Methods and apparatus for phototherapy
ZA202206163B (en) Methods of treating coronavirus
IL273155A (en) Methods for treating depression and major depressive disorder
AU2020901810A0 (en) Methods for treating major depressive disorder and treatment-resistant depression
EP4100061A4 (en) Combination therapies and biomarkers for treating cancer
GB202019767D0 (en) Compostitions and methods
EP3946419A4 (en) Methods of treating cancer with chk1 inhibitors
IL286305A (en) Methods of treating borderline personality disorder
IL291609A (en) Methods for treating acute wounds and improving outcomes
IL306119A (en) Gene therapy for treating beta-hemoglobinopathies
IL288353A (en) Methods of treating cholangiocarcinoma
EP3995147A4 (en) Substance and method for treating tumor
EP3955943A4 (en) Gmci and ddri combination therapy for treating cancer
GB2597582B (en) Ion source and method
IL309296A (en) Methods and compositions for treating an angiotensinogen- (agt-) associated disorder
EP4045147A4 (en) Materials and methods for treating vitiligo
EP4189933C0 (en) Methods and apparatuses for policy control